-
公开(公告)号:US12076306B2
公开(公告)日:2024-09-03
申请号:US18144890
申请日:2023-05-09
发明人: Tarek A. Zeidan , Scott Duncan , Christopher P. Hencken , Thomas Andrew Wynn , Carlos N. Sanrame
IPC分类号: C07C235/88 , A61K31/225 , C07C219/08 , C07C229/16 , C07C233/18 , C07C233/91 , C07C317/18 , C07C317/28 , C07D207/06 , C07D207/40 , C07D209/52 , C07D211/06 , C07D211/38 , C07D295/088 , C07D491/113
CPC分类号: A61K31/225 , C07C219/08 , C07C229/16 , C07C233/18 , C07C233/91 , C07C235/88 , C07C317/18 , C07C317/28 , C07D207/06 , C07D207/40 , C07D209/52 , C07D211/06 , C07D211/38 , C07D295/088 , C07D491/113
摘要: The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
-
公开(公告)号:US11083703B2
公开(公告)日:2021-08-10
申请号:US16790849
申请日:2020-02-14
发明人: Tarek A. Zeidan , Scott Duncan , Christopher P. Hencken , Thomas Andrew Wynn , Carlos N. Sanrame
IPC分类号: C07C235/88 , A61K31/225 , C07D491/113 , C07C317/28 , C07D211/38 , C07D295/088 , C07D207/40 , C07D211/06 , C07D207/06 , C07D209/52 , C07C317/18 , C07C219/08 , C07C229/16 , C07C233/18 , C07C233/91
摘要: The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
-
公开(公告)号:US20200016111A1
公开(公告)日:2020-01-16
申请号:US16524498
申请日:2019-07-29
发明人: Tarek A. Zeidan , Scott Duncan , Christopher P. Hencken , Thomas Andrew Wynn , Carlos N. Sanrame
IPC分类号: A61K31/225 , C07D491/113 , C07C317/28 , C07D211/38 , C07D295/088 , C07D207/40 , C07D211/06 , C07D207/06 , C07D209/52 , C07C317/18 , C07C219/08 , C07C229/16 , C07C233/18 , C07C233/91
摘要: The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
-
公开(公告)号:US10155772B2
公开(公告)日:2018-12-18
申请号:US15988498
申请日:2018-05-24
发明人: Scott Duncan
IPC分类号: C07D491/18 , C07D221/28 , C07D489/08 , C07D491/20
摘要: The present invention relates to compounds of formula I and a process for the synthesis: The invention further relates to a process for the synthesis of 3-carboxamide substituted morphinans where a 3-cyano substituted 6-oxo substituted morphinan is reacted with a 1,3-diol.
-
公开(公告)号:US20180042881A1
公开(公告)日:2018-02-15
申请号:US15782128
申请日:2017-10-12
发明人: Tarek A. Zeidan , Scott Duncan , Christopher P. Hencken , Thomas Andrew Wynn , Carlos N. Sanrame
IPC分类号: A61K31/225 , C07C317/18 , C07D207/40 , C07D295/088 , C07D211/38 , C07C317/28 , C07C229/16 , C07D207/06 , C07D211/06 , C07C219/08 , C07C233/91 , C07C233/18 , C07D491/113 , C07D209/52
CPC分类号: A61K31/225 , C07C219/08 , C07C229/16 , C07C233/18 , C07C233/91 , C07C317/18 , C07C317/28 , C07D207/06 , C07D207/40 , C07D209/52 , C07D211/06 , C07D211/38 , C07D295/088 , C07D491/113
摘要: The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
-
6.
公开(公告)号:US20140275048A1
公开(公告)日:2014-09-18
申请号:US14212745
申请日:2014-03-14
发明人: Tarek A. Zeidan , Scott Duncan , Christopher P. Hencken , Thomas Andrew Wynn , Carlos N. Sanrame
IPC分类号: C07D491/113 , C07C317/28 , C07C229/22 , C07D209/52 , C07D295/088 , C07D207/40 , C07D211/06 , C07D207/06 , C07C229/24 , C07D211/38
CPC分类号: A61K31/225 , C07C219/08 , C07C229/16 , C07C233/18 , C07C233/91 , C07C317/18 , C07C317/28 , C07D207/06 , C07D207/40 , C07D209/52 , C07D211/06 , C07D211/38 , C07D295/088 , C07D491/113
摘要: The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
摘要翻译: 本发明提供式(I)化合物及其药物组合物。
-
公开(公告)号:US11230548B2
公开(公告)日:2022-01-25
申请号:US16987581
申请日:2020-08-07
发明人: Tarek A. Zeidan , Scott Duncan , Christopher P. Hencken , Thomas Andrew Wynn , Carlos N. Sanrame
IPC分类号: C07C229/12 , C07C317/18 , C07C317/28 , C07D491/113 , A61K31/4015 , C07D207/40 , C07D207/12 , C07C229/18 , C07D207/408 , C07D211/92 , C07D295/088
摘要: The present invention provides compounds of formula (I), wherein: R1 is unsubstituted C1-C6 alkyl; La is substituted or unsubstituted C1-C6 alkyl linker, substituted or unsubstituted C3-C10 carbocycle, substituted or unsubstituted heterocycle comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S, or substituted or unsubstituted heteroaryl comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S; and R2 and R3 are each, independently, H, substituted or unsubstituted C1-C6 alkyl, or substituted or unsubstituted C6-C10 aryl; or alternatively, R2 and R3, together with the nitrogen atom to which they are attached, form a substituted or unsubstituted heteroaryl comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S or a substituted or unsubstituted heterocycle comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S. The invention also provides pharmaceutical compositions and methods for treating neurological diseases, such as multiple sclerosis.
-
公开(公告)号:US20190382413A1
公开(公告)日:2019-12-19
申请号:US16221884
申请日:2018-12-17
发明人: Tarek A. Zeidan , Scott Duncan , Christopher P. Hencken , Thomas Andrew Wynn , Carlos N. Sanrame
IPC分类号: C07D491/113 , C07D295/088 , C07D211/92 , C07D207/408 , C07C317/28 , C07C317/18 , C07C229/18 , C07C229/12 , C07D207/12 , C07D207/40 , A61K31/4015
摘要: The present invention provides compounds of formula (I), wherein: R1 is unsubstituted C1-C6 alkyl; La is substituted or unsubstituted C1-C6 alkyl linker, substituted or unsubstituted C3-C10 carbocycle, substituted or unsubstituted heterocycle comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S, or substituted or unsubstituted heteroaryl comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S; and R2 and R3 are each, independently, H, substituted or unsubstituted C1-C6 alkyl, or substituted or unsubstituted C6-C10 aryl; or alternatively, R2 and R3, together with the nitrogen atom to which they are attached, form a substituted or unsubstituted heteroaryl comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S or a substituted or unsubstituted heterocycle comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S. The invention also provides pharmaceutical compositions and methods for treating neurological diseases, such as multiple sclerosis.
-
公开(公告)号:US20180030063A1
公开(公告)日:2018-02-01
申请号:US15683189
申请日:2017-08-22
发明人: Tarek A. Zeidan , Scott Duncan , Christopher P. Hencken , Thomas Andrew Wynn , Carlos N. Sanrame
IPC分类号: C07D491/113 , C07C229/18 , C07C317/18 , C07C317/28 , C07D207/408 , C07D211/92 , C07D295/088 , C07C229/12 , C07D207/12 , C07D207/40 , A61K31/4015
CPC分类号: C07D491/113 , A61K31/4015 , C07C229/12 , C07C229/18 , C07C317/18 , C07C317/28 , C07D207/12 , C07D207/40 , C07D207/408 , C07D211/92 , C07D295/088
摘要: The present invention provides compounds of formula (I), wherein: R1 is unsubstituted C1-C6 alkyl; La is substituted or unsubstituted C1-C6 alkyl linker, substituted or unsubstituted C3-C10 carbocycle, substituted or unsubstituted heterocycle comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S, or substituted or unsubstituted heteroaryl comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S; and R2 and R3 are each, independently, H, substituted or unsubstituted C1-C6 alkyl, or substituted or unsubstituted C6-C10 aryl; or alternatively, R2 and R3, together with the nitrogen atom to which they are attached, form a substituted or unsubstituted heteroaryl comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S or a substituted or unsubstituted heterocycle comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S. The invention also provides pharmaceutical compositions and methods for treating neurological diseases, such as multiple sclerosis.
-
公开(公告)号:US09775823B2
公开(公告)日:2017-10-03
申请号:US15295370
申请日:2016-10-17
发明人: Tarek A. Zeidan , Scott Duncan , Christopher P. Hencken , Thomas Andrew Wynn , Carlos N. Sanrame
IPC分类号: A61K31/225 , C07D491/113
CPC分类号: A61K31/225 , C07C219/08 , C07C229/16 , C07C233/18 , C07C233/91 , C07C317/18 , C07C317/28 , C07D207/06 , C07D207/40 , C07D209/52 , C07D211/06 , C07D211/38 , C07D295/088 , C07D491/113
摘要: The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
-
-
-
-
-
-
-
-
-